
See exactly how PRHSX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PRHSX and 80,000+ other tickers.
This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on the research, development, manufacturing, or distribution of offerings related to healthcare, medicine, or the broader life sciences. While the portfolio has the liberty to invest in companies of any market capitalization, most of its holdings are projected to be in large- and medium-sized corporations. The fund operates as a non-diversified investment vehicle.
No recent news available.